YES1 and liver cancer: These findings identify YES as an oncogenic driver in liver cancer.4 To evaluate the cell-autonomous role of YES in sustaining the proliferation of HCC cells in vivo, we engineered HCC cells with an inducible YES1 shRNA and transplanted the cells in immunodeficient mice.